Critical issues of PTH assays in CKD
Authors:
- Hirotaka KomabaHKHirotaka Komaba
- Shunsuke GotoSGShunsuke Goto
- Masafumi FukagawaMFMasafumi Fukagawa
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Stability of intact parathyroid hormone in samples from hemodialysis patientsKidney International, 2007
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association With Mortality in Dialysis PatientsAmerican Journal of Kidney Diseases, 2005
- Normalization of reversed bio-intact-PTH(1-84)/intact- PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidismClinical Nephrology, 2005
- Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover boneNephrology Dialysis Transplantation, 2005
- With or without the kidney: the role of FGF23 in CKDNephrology Dialysis Transplantation, 2005
- Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidismNephrology Dialysis Transplantation, 2004
- Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidismSurgery, 2004
- Amino-Terminal Form of Parathyroid Hormone (PTH) with Immunologic Similarities to hPTH(1–84) Is Overproduced in Primary and Secondary HyperparathyroidismClinical Chemistry, 2003
- Metabolism of Parathyroid Hormone by Isolated Rat Kupffer Cells and HepatocytesJournal of Clinical Investigation, 1981